Daily ingestion of low dose aspirin has been thought to be beneficial for a long time. The question now, as asked by a U.K. report published in Drug and Therapeutics Bulletin, is if the risks outweigh the benefits.

A new study by British scientists indicates that healthy people who may be taking a daily dose of aspirin as a preventative against heart disease may be doing themselves more harm than good.

Millions of people take low dose aspirin every day to lower their risk of a heart attack by a fifth, but aspirin increases the risk of stomach bleeding by a third. Scientists at Oxford have concluded that the benefits of aspirin only outweigh the risks in the cases of patients who have already had a stroke or a heart attack.

Scientists in the United Kingdom are reporting new evidence that humans can make their own salicylic acid (SA) — the material formed when aspirin breaks down in the body.

Scientists in the United Kingdom are reporting new evidence that humans can make their own salicylic acid (SA) — the material formed when aspirin breaks down in the body.

Two very popular aspirin products by Bayer received FDA warnings today. Bayer Aspirin with Heart Advantage and Women’s Aspirin plus Calcium could harm consumers regulators say. The FDA originally approved the drugs but not for the use of preventing osteoporosis and high cholesterol which the labels on the drugs state.

The prevention of progression of arterial disease and diabetes: a factorial randomized placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease

Aspirin has become one of the most widely used medications in the world, owing to its ability to reduce pain, fevers, inflammation, and blood clotting.

Researchers at the University of Southern California, School of Dentistry have uncovered the health benefits of aspirin in the fight against osteoporosis.

Aspirin-like compounds (salicylates) can claim another health benefit: increasing the amount of insulin produced by otherwise healthy obese people. Obesity is associated with insulin resistance, the first step toward type 2 diabetes.

Researchers in Italy report development of a new group of aspirin-like substances that may be safer and as effective as conventional aspirin for fighting heart disease, the leading cause of death in the developed world. Their study is scheduled for the March 27 issue of the ACS’ Journal of Medicinal Chemistry.

Stroke patients who use ibuprofen for arthritis pain or other conditions while taking aspirin to reduce the risk of a second stroke undermine aspirin's ability to act as an anti-platelet agent, researchers at the University at Buffalo have shown.